Literature DB >> 305223

Plasma cofactors of platelet function: correlation with diabetic retinopathy and hemoglobins Ala-c.

B S Coller, R N Frank, R C Milton, H R Gralnick.   

Abstract

We studied 29 diabetic patients (eight without and 21 with retinopathy) and 29 matched control subjects for hemoglobins Ala-c and plasma levels of fibrinogen, von Willebrand factor, and factor VIII/von Willebrand factor antigen. Hemoglobins Ala-c were elevated in all diabetic patients, regardless of retinopathy (P less than 0.001); fibrinogen was elevated only in those with retinopathy (P less than 0.001); and plasma von Willebrand factor was clearly elevated in those with proliferative retinopathy and minimally, if at all, elevated in those with background or no retinopathy. Plasma from five diabetic patients with proliferative retinopathy and five control subjects was tested for its ability to enhance the ADP-induced platelet aggregation of normal or von Willebrand platelet-rich plasma; no differences were found. We conclude that elevated levels of fibrinogen and von Willebrand factor, both recognized plasma cofactors of platelet function, are associated with proliferative diabetic retinopathy. A plasma factor that enhances ADP-induced platelet aggregation could not be found in diabetic plasma, and we doubt that increased von Willebrand factor is responsible for its finding by others.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 305223     DOI: 10.7326/0003-4819-88-3-311

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  17 in total

1.  Changes in the factor VIII complex in diabetic ketoacidosis: evidence of endothelial cell damage?

Authors:  M Greaves; C Pickering; G Knight; A J Boulton; J Ball; J D Ward; F E Preston
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

2.  Retinal cotton-wool spots: an early finding in diabetic retinopathy?

Authors:  M S Roy; M E Rick; K E Higgins; J C McCulloch
Journal:  Br J Ophthalmol       Date:  1986-10       Impact factor: 4.638

Review 3.  Endothelial cell function in diabetic microangiopathy.

Authors:  M Porta; M La Selva; P Molinatti; G M Molinatti
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

4.  Factor VIII related antigen in the assessment of vasculitis.

Authors:  A D Woolf; G Wakerley; T B Wallington; D G Scott; P A Dieppe
Journal:  Ann Rheum Dis       Date:  1987-06       Impact factor: 19.103

5.  Relationships between metabolic and hemostatic variables in uncomplicated diabetes.

Authors:  C Vergani; G Bettale; D Mari; P M Mannucci
Journal:  Acta Diabetol Lat       Date:  1981 Jul-Sep

6.  Studies of retinopathy and the plasma co-factor of platelet hyperaggregation in type 1 (insulin-dependent) diabetic children.

Authors:  R D Levin; H C Kwaan; J G Dobbie; C L Fetkenhour; H S Traisman; C Kramer
Journal:  Diabetologia       Date:  1982-06       Impact factor: 10.122

Review 7.  The role of endothelium in the pathogenesis of diabetic microangiopathy.

Authors:  M La Selva; E Beltramo; P Passera; M Porta; G M Molinatti
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

Review 8.  Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects.

Authors:  A Ceriello
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

9.  Chlorpropamide-alcohol flushing in non insulin-dependent diabetes: prevalence of small and large vessel disease and or risk factors for angiopathy.

Authors:  P Micossi; P M Mannucci; M C Librenti; U Raggi; A D'Angelo; S Corallo; B Garimberti; S Bozzini; E Malacco
Journal:  Acta Diabetol Lat       Date:  1982 Apr-Jun

10.  Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins.

Authors:  A M Schmidt; M Hasu; D Popov; J H Zhang; J Chen; S D Yan; J Brett; R Cao; K Kuwabara; G Costache
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.